[1]Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005,55(2):74-108.
[2]McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma[J]. Best Pract Res Clin Gastroenterol, 2005,19(1):3-23.
[3]El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis[J]. Gastroenterology, 2007,132(7):2557-2576.
[4]Ding XZ, Hennig R, Adrian TE. Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer[J]. Mol Cancer, 2003,7(2):10-11.
[5]Steele VE, Holmes CA, Hawk ET, et al. Lipoxygenase inhibitors as potential cancer chemopreventives[J]. Cancer Epidemiol Biomarkers Prev,1999,8(5):467-483.
[6]Matsuyama M, Yoshimura R, Mitsuhashi M, et al. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors[J]. Int J Oncol, 2004,24(4):821-827.
[7]Zhi H, Zhang J, Hu G, et al. The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma[J]. Int J Cancer,2003,106(3):327-333.
[8]Yoshimura R, Inoue K, Kawahito Y, et al. Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor[J]. Int J Mol Med, 2004,13(1):41-46.
[9]Yoshimura R, Matsuyama M, Tsuchida K,et al. Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors[J]. J Urol,2003,170(5):1994-1999.
[10]Pidgeon GP, Tang K, Cai YL, et al. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression[J]. Cancer Res,2003,63(14):4258-4267.
[11]Nie D, Nemeth J, Qiao Y, et al . Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase[J]. Clin Exp Metastasis,2003,20(7):657-663.
[12]Pidgeon GP, Kandouz M, Meram A, et al. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells[J]. Cancer Res, 2002,62(9):2721-2727.
[13]Wong BC, Wang WP, Cho CH, et al. 12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells[J]. Carcinogenesis,2001,22(9):1349-1354.
[14]Leung HW, Yang WH, Lai MY, et al. Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis[J]. Food Chem Toxicol,2007,45(3):403-411.
[15]Burlacu A. Regulation of apoptosis by Bcl-2 family proteins[J]. J Cell Mol Med,2003,7(3):249-257.
[16]Porter AG, Jnicke RU. Emerging roles of caspase-3 in apoptosis[J]. Cell Death Differ, 1999,6(2):99-104.
[17]Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions[J]. Endocr Rev,2001,22(2):153-183.
[18]Balmanno K,Cook SJ.Tumour cell survival signalling by the ERK1/2 pathway[J].Cell Death Differ,2009,16(3):368-377.
[19]Ito Y, Sasaki Y, Horimoto M, et al. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma[J]. Hepatology,1998,27(4):951-958.
[20]Mitsushima M, Suwa A, Amachi T, et al. Extracellular signal-regulated kinase activated by epidermal growth factor and cell adhesion interacts with and phosphorylates vinexin[J]. J Biol Chem,2004,279(33):34570-34577.
[21]Ding XZ, Tong WG, Adrian TE. 12-lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation[J]. Int J Cancer,2001,94(5):630-636.(编校:张志明)